Título Treatment with bortezomib of human CD4+ T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population Editorial Ferrata Storti Foundation Descripción Documento Fuente Haematologica, 2009, Vol. 94, Nº. 7, págs. 975-983 Resumen Background In vitro depletion of alloreactive T cells using the proteasome inhibitor bortezomib is a promising approach to prevent graft-versus-host disease after allogeneic stem cell transplantation.
